Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

506

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

September 30, 2009

Conditions
Hypertension
Interventions
DRUG

Fimasartan

Fimasartan 60 \~ 120mg/po take one tablets once a day

DRUG

Losartan (Control)

Losartan 50 mg \~ 100 mg/po, take one tablets once a day

Sponsors
All Listed Sponsors
collaborator

Seoul National University Hospital

OTHER

collaborator

The Catholic University of Korea

OTHER

collaborator

Kangbuk Samsung Hospital

OTHER

collaborator

Konkuk University Medical Center

OTHER

collaborator

Konyang University Hospital

OTHER

collaborator

Keimyung University

OTHER

collaborator

Korea University

OTHER

collaborator

Korea University Guro Hospital

OTHER

collaborator

Dongguk University International Hospital

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

Samsung Medical Center

OTHER

collaborator

Asan Medical Center

OTHER

collaborator

Severance Hospital

OTHER

collaborator

Ajou University

OTHER

collaborator

Wonju Severance Christian Hospital

OTHER

collaborator

Yeungnam University Hospital

OTHER

collaborator

Yonsei University

OTHER

collaborator

Inha University Hospital

OTHER

collaborator

Chonbuk National University Hospital

OTHER

collaborator

Cheil General Hospital and Women's Healthcare Center

OTHER

collaborator

Chungnam National University

OTHER

collaborator

Chungbuk National University Hospital

OTHER

collaborator

Hanyang University

OTHER

lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY

NCT00922480 - Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients | Biotech Hunter | Biotech Hunter